Bruntwood SciTech has hailed the 海角视频's move to re-join the EU's £85bn Horizon research programme as "unequivocally positive".
The joint venture between property giant Bruntwood and Legal & General said the 海角视频's involvement in the project is "integral to the future success of the life sciences sector and the wider economy".
Researchers based in the 海角视频 can from Thursday apply for grants to take part in the collaboration programme after Rishi Sunak secured what he called "the right deal for British taxpayers".
READ MORE: Click here to sign up to the BusinessLive North West newsletter
According to the EU's estimate, Britain will contribute around £2.2bn per year to participate in both Horizon and the Copernicus space programme from January 1, when its association membership with the projects begins. But it will not take part in the bloc’s nuclear technology scheme Euratom.
With costs a key barrier for negotiators to overcome, the 海角视频 will not have to pay into the scheme for the two years it was frozen out in a tit-for-tat retaliation in a dispute over post-Brexit trading arrangements for Northern Ireland in 2020.
Dr Kath Mackay, director of life sciences for Bruntwood SciTech, said: "The 海角视频's involvement in Horizon is integral to the future success of the life sciences sector and the wider economy, so our return to the fold is unequivocally positive.
"海角视频-led R&D risked being all the poorer for the loss of both funding and fellowship, and this deal will go some way to kickstarting inward investment that had stalled or been withdrawn over the past 18 months.
Most Read
"Challenges remain though in supporting the 海角视频's future status as a science superpower in line with government ambition – notably, the paucity of high-quality lab space across the 海角视频.
"While the golden triangle remains a flagbearer for the 海角视频 internationally, it’s pleasing to see developers and investors – Bruntwood SciTech included – recognising and backing the growth of R&D clusters in the regions.
"Cities like Manchester, Birmingham and Glasgow have created compelling propositions for investment, and the onus is on us to continue connecting their world-class research institutes and local leadership with industry to help commercialise the R&D within these emerging hubs – not just through infrastructure but also specialist support."